Having considered seeking investment through venture capital, The Hospital Group - which is based at Dolan Park - chose to ensure the certainty of the company’s finances by remaining independent.
This decision will ensure The Group remains free from external influence and in a solid position to deliver the core company mission to provide an excellent patient experience.
David Ross, Chief Executive of The Hospital Group, said: “By excluding external investors, The Hospital Group is now in a strong position to control its own agenda for future development and we are really excited about the potential that this opens up for us.”
The restructure has seen two shareholders either reduce or sell their shares, while David Ross increases his holding to gain day to day control and Steve McNerlin remains majority shareholder.
Mr Ross added: “The restructure gives us a solid base from which we can deliver our strategic company vision to be the market leader in the UK and Ireland for the provision of elective lifestyle surgery and treatments, recognised for quality, value and innovation.
“We will introduce new treatments and procedures and expand into selected international markets where this complements the core business.”
This latest move follows the acquisition of Marbella-based Mills & Mills earlier this year and the appointment of leading surgeon Mr Mario Russo, while plans to expand further into the USA are also on the cards.
Since The Hospital Group was established in 1992, it has grown from a small pharmaceutical company to one of the UK’s foremost cosmetic and gastric surgery providers. The Hospital Group is committed to providing the very highest standards and all procedures are performed by an expert medical team in state-of-the-art facilities that are second to none.
For further information of The Hospital Group’s range of gastric procedures, surgery-seekers should visit the website www.thehospitalgroup.org or call our patient care coordinators on 0845 762 6727.